Revitas, Inc., the leader in revenue acceleration, announced today that it has been selected by one of the largest generics and specialty pharmaceutical companies in the world to deliver an end-to-end revenue management solution and standardize the organization’s worldwide operations onto a single integrated technology platform. The company has selected the combined team of Alliance Life Sciences and KPMG LLP to assist with its systems integration, business analysis, and design advisory service needs, and to support the global implementation of the Revitas platform.
The company, a 15-year Revitas customer, will upgrade to the Revitas® Flex® platform and implement the Revitas Revenue Manager™ suite, including Revitas Validata®, Contract Manager, Government Pricing, Medicaid Rebates, and Analytics applications.
The implementation supports the company’s strategic objectives to standardize and automate all technology from a global perspective, optimize revenue across all phases of its product lifecycle, and improve business processes with unified applications that integrate with its SAP® enterprise resource planning (ERP) system. The Revitas revenue management suite delivers best-of-breed technology for managing financial accruals, international product launch sequencing, global reference pricing, bid-and-tender management, and gross-to-net financial analysis. Multi-language and currency capabilities allow business units across global regions to collaborate within the system.
The Revitas Flex platform offers the pharmaceutical company a robust analytic engine that drives strategic insight into customer, contract, and product performance in order to make more effective contracting decisions and gain greater control over complex partner agreements across global distribution networks. Its ability to unify non-integrated, legacy systems provides data conversion at the detail level, reducing risk and ensuring audit and resubmissions compliance.
“In today’s fast-paced, global market it is essential for organizations to integrate revenue management and pricing strategies with business intelligence in order to remain competitive,” said Brian Madocks, CEO and President of Revitas. “Revitas’s revenue management cloud technology helps companies improve efficiencies, streamline and simplify processes, reduce risk, and gain valuable business insight across the organization – all resulting in increased profitability and operational excellence.”
“By joining the strengths of the Revitas revenue management platform with the global pricing management capabilities and strategic pricing analytics Alliance Life Sciences provides, our partnership delivers an integrated solution that addresses global pricing needs across an organization,” stated Alan Crowther, Chief Executive Officer, Alliance Life Sciences. “This project is a perfect example of the value the Revitas/Alliance Life Sciences partnership brings to the market.”
About Alliance Life Sciences
Alliance Life Sciences is a global innovator that delivers peace of mind and unlocks business value with unique solutions to complex commercial problems. With over ten years of dedicated life sciences experience, our worldwide team of experts provides insights into contracting, pricing, and access. We serve mid-market life sciences companies and eight of the top-10 pharmaceutical manufacturers as well as multiple medical device and diagnostic firms. Contact: 866.581.4850 or www.alscg.com.